Every material Form 8-K DXP Enterprises has filed with the SEC since March 07, 2024, read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). Newest first; each brief links to its own page and to the filing on SEC.gov.
DXP Enterprises reported third quarter 2026 results for the period ended September 30, 2026, with sales of $587.2 million, up 14.3% from a year earlier, and net income of $26.9 million, up 24.2%. Diluted earnings per share were $1.64 compared with $1.31 in the third quarter of 2025, and the company completed five acquisitions through the quarter.
Sales were $587.2 million versus $513.7 million in the third quarter of 2025; acquisitions contributed $48.8 million.
Net income was $26.9 million versus $21.6 million; diluted EPS was $1.64 versus $1.31.
Adjusted EBITDA was $67.3 million, up 19.0%, with an Adjusted EBITDA margin of 11.5% versus 11.0%.
Free cash flow was $14.4 million versus $28.1 million a year earlier; total debt was $839.5 million as of September 30, 2026.
DXP Enterprises' Board authorized a new program to repurchase up to $150.0 million or 1.0 million shares of common stock over the next 24 months, at management's discretion. The new program follows a previous $85.0 million or 2.5 million share program that concluded in August 2026, and the company may discontinue it at any time.
Up to $150.0 million or 1.0 million shares may be repurchased over the next 24 months
Previous program authorized up to $85.0 million or 2.5 million shares and concluded in August 2026
Approximately 16.4 million diluted weighted average shares outstanding as of June 30, 2026
Repurchases may occur in open market or privately negotiated transactions; no guarantee of exact amount
DXP Enterprises reported second quarter 2026 results for the period ended June 30, 2026. Sales rose 15.6% year over year to $576.5 million, and GAAP diluted EPS was $1.76, up from $1.43, while net income increased 21.6% to $28.7 million. The filing gives no financial guidance, and the company said it closed four acquisitions in the first half of 2026.
Sales of $576.5 million, up 15.6% from $498.7 million; acquisitions contributed $49.8 million
GAAP diluted EPS of $1.76 versus $1.43; Adjusted EBITDA of $70.4 million, up 22.8%
Free cash flow of $29.8 million versus $8.3 million a year earlier; total debt was $842.5 million at June 30, 2026
DXP Enterprises entered a Second Amended and Restated Loan Agreement on July 2, 2026, increasing commitments under its asset-based revolving credit facility by $40 million. The facility now totals $225 million and matures on July 2, 2031. The company says the change maintains liquidity, supports its acquisition strategy, and positions it to optimize its cost of capital.
Total ABL commitments rise from $185 million to $225 million, a $40 million increase.
Up to $210 million is available to US borrowers and up to $15 million to Canadian borrowers.
Interest accrues at Term SOFR or Term CORRA plus 1.25% to 1.75%, or at alternate base rates plus 0.25% to 0.75%, based on average daily excess availability.
The facility may be increased by up to $50 million in total, in minimum increments of $10 million, subject to conditions; Bank of America, N.A. is agent.
DXP Enterprises reported first quarter 2026 results for the period ended March 31, 2026. Sales rose 9.5% to $521.7 million, but net income fell to $20.0 million from $20.6 million and diluted EPS fell to $1.22 from $1.25, so headline profit measures declined while revenue grew.
Sales were $521.7 million, up from $476.6 million a year earlier, with Innovative Pumping Solutions up 37.7% to $118.7 million.
Net income was $20.0 million versus $20.6 million; diluted EPS was $1.22 versus $1.25 on 16.4 million diluted shares.
Adjusted EBITDA rose to $57.8 million from $52.5 million, and the company completed three acquisitions through the first quarter.
Total debt was $844.7 million at March 31, 2026, and cash was $213.4 million.
DXP Enterprises reported fourth-quarter and fiscal 2025 results on February 25, 2026. Sales and net income rose in both periods, with Q4 diluted EPS up to $1.39 from $1.29 and full-year diluted EPS up to $5.37 from $4.22. The filing gives no forward guidance, and the company said it raised an incremental $205 million under its Term Loan B during the fourth quarter.
Q4 2025 sales rose 12.0% to $527.4 million; Q4 net income rose 6.9% to $22.8 million
Q4 diluted EPS was $1.39 vs. $1.29 a year earlier; adjusted diluted EPS was $1.39 vs. $1.38
Fiscal 2025 sales rose 11.9% to $2.0 billion; net income rose 25.8% to $88.7 million
Refinancing raised an incremental $205 million and cut borrowing costs by 50 basis points; cash was $303.8 million at year end
DXP Enterprises closed a refinancing of its existing Senior Secured Term Loan B and raised an incremental $205 million, bringing total term loan borrowings to $848 million. The company says the transaction cuts its borrowing margin by 50 basis points and is expected to save an estimated $3.2 million in annual interest, with proceeds used to repay existing debt and for general corporate purposes and acquisitions. Shareholders should note the larger debt load, which is secured by substantially all of the company's assets.
Total Term Loan B borrowings of $848 million, including $643.0 million refinanced and a $205 million increase, maturing October 13, 2030
Priced at Term SOFR plus 3.25 percent; applicable margin reduced by 50 basis points
Company estimates $3.2 million in annual interest savings
Loan is secured by substantially all consolidated assets, with a secured leverage covenant of 5.75:1 to 4.75:1
DXP Enterprises reported third quarter 2025 results for the period ended September 30, 2025. Sales rose 8.6% year over year to $513.7 million, net income rose 2.5% to $21.6 million, and GAAP diluted EPS was $1.31, up from $1.27. The company also said it had completed three acquisitions through the third quarter and two more after quarter end.
Sales of $513.7 million, up 8.6% from $472.9 million in Q3 2024 and up 3.0% from $498.7 million in Q2 2025
GAAP diluted EPS of $1.31 vs. $1.27 in Q3 2024; adjusted diluted EPS of $1.34 vs. $1.43
Adjusted EBITDA of $56.5 million vs. $52.4 million; Supply Chain Services revenue fell 5.0% to $63.0 million
Total debt outstanding was $644.0 million and cash was $123.8 million as of September 30, 2025
DXP Enterprises reported second quarter 2025 results on August 6, 2025, with sales of $498.7 million, up 11.9% from a year earlier, and net income of $23.6 million, up 41.3%. Diluted earnings per share were $1.43, compared with $1.00 in the second quarter of 2024, and Adjusted EBITDA rose to $57.3 million. The filing gives no new full-year guidance, and the company said it expects at least three or four more acquisitions in the second half of 2025.
Sales of $498.7 million, up 11.9% from $445.6 million in Q2 2024 and up 4.6% from $476.6 million in Q1 2025
Diluted EPS of $1.43 versus $1.00 in Q2 2024; net income of $23.6 million versus $16.7 million
Adjusted EBITDA of $57.3 million, an 11.5% margin, versus $48.2 million (10.8% margin) in Q2 2024
Free cash flow of $8.3 million versus $5.9 million a year earlier; total debt outstanding was $626.8 million as of June 30, 2025
DXP Enterprises entered an Increase Agreement on July 1, 2025, raising commitments under its existing asset-based revolving credit facility from $135 million to $185 million. The company says the added capacity provides liquidity and flexibility for its acquisition strategy, and the other terms of the facility were not amended.
Commitments under the ABL Facility rose by $50 million, from $135 million to $185 million, under an Increase Agreement dated July 1, 2025.
Up to $175.0 million is available to US borrowers and up to $10.0 million to Canadian borrowers.
Other material terms of the ABL Facility remain in effect and were not otherwise amended, according to the filing.
Goldman Sachs Bank USA is listed as lender and Bank of America, N.A. as agent for the lenders.
DXP Enterprises reported first-quarter 2025 results, with sales up 15.5% year over year to $476.6 million and net income of $20.6 million, compared with $11.3 million a year earlier. Diluted EPS rose to $1.25 from $0.67, though free cash flow was negative $16.9 million, compared with positive $24.1 million in the first quarter of 2024.
Sales of $476.6 million vs. $412.6 million in Q1 2024; acquisitions added $31.1 million
Diluted EPS of $1.25 vs. $0.67; Adjusted EBITDA of $52.5 million vs. $40.3 million
Free cash flow of negative $16.9 million vs. positive $24.1 million; purchases of property and equipment were $19.9 million
Cash of $114.3 million and total debt of $647.3 million as of March 31, 2025
DXP Enterprises reported fourth-quarter and fiscal 2024 results in a press release furnished under Item 2.02. Fourth-quarter sales rose to $470.9 million from $407.0 million, and diluted EPS rose to $1.29 from $0.94. For the full year, sales grew 7.4 percent to $1.8 billion and net income reached $70.5 million, up from $68.8 million, so shareholders saw higher sales and profit on both measures.
Q4 2024 sales were $470.9 million versus $407.0 million in Q4 2023; diluted EPS was $1.29 versus $0.94.
Fiscal 2024 diluted EPS was $4.22 versus $3.89 in fiscal 2023; net income was $70.5 million versus $68.8 million.
Fiscal 2024 free cash flow was $77.1 million, down from $94.0 million in fiscal 2023.
The company refinanced its Senior Secured Term Loan B, raising $649.5 million, and repurchased 0.6 million shares for $28.8 million in fiscal 2024.
DXP Enterprises reported third-quarter 2024 results in a press release dated November 4, 2024, furnished under Item 2.02 of this 8-K. Sales rose 12.8% year over year to $472.9 million and GAAP diluted EPS was $1.27, up from $0.93, while Adjusted EBITDA reached $52.4 million. Free cash flow fell to $24.4 million from $38.3 million a year earlier, and interest expense rose to $15.7 million from $12.7 million.
Sales of $472.9 million, up 12.8% from $419.2 million in Q3 2023 and up 6.1% from $445.6 million in Q2 2024
GAAP diluted EPS of $1.27 vs $0.93 in Q3 2023; Adjusted EBITDA of $52.4 million vs $44.0 million
Free cash flow of $24.4 million vs $38.3 million in Q3 2023; interest expense of $15.7 million vs $12.7 million
Total debt of $544.5 million as of September 30, 2024; company raised an incremental $105 million after repricing existing debt
DXP Enterprises reported second quarter 2024 results on August 8, 2024. Sales rose 4.1% year over year to $445.6 million, but diluted EPS fell to $1.00 from $1.06 and net income declined to $16.7 million from $19.1 million. Adjusted EBITDA rose to $48.2 million from $45.3 million, and the company said it expects to close at least two more acquisitions in the second half of 2024.
Sales of $445.6 million, up 4.1% from $428.0 million a year earlier and up 8.0% from $412.6 million in the first quarter of 2024
Diluted EPS of $1.00 versus $1.06 a year earlier; adjusted diluted EPS of $1.02 versus $1.06
Adjusted EBITDA of $48.2 million, up from $45.3 million, with a 10.8% margin versus 10.6%
Free cash flow of $30.0 million for the six months ended June 30, 2024; four acquisitions completed through the second quarter
DXP Enterprises reported first-quarter 2024 results on May 8, 2024. Sales were $412.6 million, down 2.7% from $424.3 million a year earlier, and GAAP diluted EPS was $0.67, down from $0.95, while net income fell to $11.3 million from $17.6 million. Acquisitions contributed $11.8 million of sales, and the company generated $24.1 million of free cash flow, but the year-over-year declines in sales and profit are the headline measures for shareholders.
Sales of $412.6 million, up 1.4% sequentially from $407.0 million but down 2.7% from $424.3 million in Q1 2023
GAAP diluted EPS of $0.67 versus $0.95 a year earlier; non-GAAP diluted EPS of $0.74
Adjusted EBITDA of $40.3 million versus $43.1 million; free cash flow of $24.1 million, up 6.4%
Cash of $139.7 million and net debt of $407.6 million at March 31, 2024; CFO expects growth to be driven by the second half of 2024
DXP Enterprises reported fourth quarter and fiscal 2023 results. Q4 diluted EPS was $0.94 versus $0.37 a year earlier, while Q4 sales were $407.0 million compared with $406.3 million. For the full year, sales rose 13.4% to $1.7 billion and net income increased to $68.8 million from $48.2 million, a result that favors shareholders on the headline measures.
Q4 2023 diluted EPS was $0.94 versus $0.37 in Q4 2022; Q4 sales were $407.0 million versus $406.3 million.
Fiscal 2023 sales were $1.7 billion, up 13.4%, and net income was $68.8 million versus $48.2 million.
Adjusted EBITDA for fiscal 2023 was $174.3 million versus $126.8 million, and free cash flow was $94.0 million.
In fiscal 2023 the company refinanced its Senior Secured Term Loan B, raising $550 million, and repurchased 1.7 million shares for $54.7 million.
Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.
Only material 8-Ks get a brief: results, deals, executive changes, restructuring, impairments, delisting notices, restatements, cybersecurity incidents and other disclosed events. Routine filings (vote results, exhibits only) are skipped. Every DXP Enterprises filing is on SEC EDGAR ↗. 8-K briefs of other companies →